JP2022529541A5 - - Google Patents

Info

Publication number
JP2022529541A5
JP2022529541A5 JP2021563666A JP2021563666A JP2022529541A5 JP 2022529541 A5 JP2022529541 A5 JP 2022529541A5 JP 2021563666 A JP2021563666 A JP 2021563666A JP 2021563666 A JP2021563666 A JP 2021563666A JP 2022529541 A5 JP2022529541 A5 JP 2022529541A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
isotope
pharmaceutically acceptable
tautomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021563666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022529541A (ja
JP7546596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/029805 external-priority patent/WO2020219871A1/en
Publication of JP2022529541A publication Critical patent/JP2022529541A/ja
Publication of JP2022529541A5 publication Critical patent/JP2022529541A5/ja
Application granted granted Critical
Publication of JP7546596B2 publication Critical patent/JP7546596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021563666A 2019-04-26 2020-04-24 ヘテロ環式化合物ならびに蠕虫感染および疾患におけるその使用 Active JP7546596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962839552P 2019-04-26 2019-04-26
US62/839,552 2019-04-26
PCT/US2020/029805 WO2020219871A1 (en) 2019-04-26 2020-04-24 Heterocyclic compounds and their use for treatment of helminthic infections and diseases

Publications (3)

Publication Number Publication Date
JP2022529541A JP2022529541A (ja) 2022-06-22
JP2022529541A5 true JP2022529541A5 (enExample) 2023-04-13
JP7546596B2 JP7546596B2 (ja) 2024-09-06

Family

ID=70775481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563666A Active JP7546596B2 (ja) 2019-04-26 2020-04-24 ヘテロ環式化合物ならびに蠕虫感染および疾患におけるその使用

Country Status (6)

Country Link
US (3) US11505548B2 (enExample)
EP (1) EP3959207A1 (enExample)
JP (1) JP7546596B2 (enExample)
KR (1) KR102939516B1 (enExample)
CN (1) CN114072395A (enExample)
WO (1) WO2020219871A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021000293A (es) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos.
JP7637630B2 (ja) 2019-03-19 2025-02-28 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
KR102939516B1 (ko) * 2019-04-26 2026-03-16 셀진 코포레이션 헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도
EP4077322A1 (en) 2019-12-18 2022-10-26 Intervet International B.V. Anthelmintic compounds comprising azaindoles structure
EP4077281A1 (en) 2019-12-18 2022-10-26 Intervet International B.V. Anthelmintic compounds comprising a quinoline structure
PH12022553222A1 (en) 2020-05-29 2024-02-12 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic heterocyclic compounds
JP7724845B2 (ja) 2020-07-24 2025-08-18 エランコ・ユーエス・インコーポレイテッド イソオキサゾリン化合物及びその中間体を作製するための方法
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형
JP2023547396A (ja) * 2020-10-23 2023-11-10 セルジーン コーポレーション 蠕虫感染及び疾患の処置のための複素環式化合物及びその使用
CN116600807A (zh) 2020-12-11 2023-08-15 英特维特国际股份有限公司 包含噻吩并吡啶结构的驱虫化合物
CN112500324B (zh) * 2020-12-12 2022-05-13 浙江大学衢州研究院 制备硫代酰胺类化合物的方法
US20240148744A1 (en) * 2021-02-09 2024-05-09 Celgene Corporation Sulfonamides and their use for treatment of helminthic infections and diseases
AR127495A1 (es) 2021-11-01 2024-01-31 Boehringer Ingelheim Vetmedica Gmbh Compuestos de pirrolopiridazina como antihelmínticos
CN115819429A (zh) * 2022-12-13 2023-03-21 成都睿智化学研究有限公司 一种5-氯-2,3-二氢呋喃[2,3-c]吡啶的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276432A3 (de) 1986-12-12 1988-10-26 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
ZA879329B (en) * 1986-12-12 1988-06-13 Ciba-Geigy Ag Pesticides
EP0664798B1 (en) * 1993-08-13 1999-12-29 Zeneca Limited Thiadiazole derivatives and their use as fungicides or insecticides
US5614470A (en) * 1994-04-01 1997-03-25 Sankyo Company, Limited 13-substituted milbemycin derivatives, their preparation and their use
JP3689462B2 (ja) * 1994-11-17 2005-08-31 三共アグロ株式会社 殺虫活性を有する１３位置換ミルベマイシン誘導体
CN1281127C (zh) 1995-11-08 2006-10-25 麦克公司 农药制剂
SK283851B6 (sk) * 1995-11-08 2004-03-02 Merck & Co., Inc. Pesticídny prostriedok obsahujúci benzoát emamectínu a spôsob jeho výroby
DE19858193A1 (de) * 1998-12-17 2000-06-21 Aventis Cropscience Gmbh 4-Trifluormethyl-3-oxadiazolylpyridine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
WO2000009500A2 (en) 1998-08-11 2000-02-24 Nihon Bayer Agrochem K.K. Nematicidal pyrazoles
AU2006206611A1 (en) 2005-01-19 2006-07-27 Bristol-Myers Squibb Company 2-phenoxy-N- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as P2Y1 receptor inhibitors for the treatment of thromboembolic disorders
CL2008000979A1 (es) 2007-04-11 2008-10-17 Sumitomo Chemical Co Proceso para producir un compuesto derivado de 2-piridin-2-il-2h-pirazol-3-fenilamida; compuestos intermediarios; el compuesto en si; composicion plaguicida que contiene a dicho compuesto; uso de dicho compuesto como plaguicida; y metodo para control
TW201210597A (en) * 2010-06-09 2012-03-16 Gilead Sciences Inc Inhibitors of hepatitis C virus
US20140031547A1 (en) * 2010-12-14 2014-01-30 Electrophoretics Limited CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
KR102939516B1 (ko) * 2019-04-26 2026-03-16 셀진 코포레이션 헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도

Similar Documents

Publication Publication Date Title
JP2023547396A5 (enExample)
JP2005508336A5 (enExample)
JP2024523839A5 (enExample)
JP2020515583A5 (enExample)
JP2020536069A5 (enExample)
AU2007227203B2 (en) 6,7,8, 9 -tetrahydro- 5H- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of TRPVL for the treatment of pain
JP2015524837A5 (enExample)
JP2007519694A5 (enExample)
RU2019103870A (ru) Ингибиторы циклин-зависимой киназы 7 (cdk7)
US8637527B2 (en) Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
JP2017505794A5 (enExample)
RU2005105692A (ru) 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс-хемокинового рецептора
CA2749040A1 (en) Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
JP2005526028A5 (enExample)
JP2019518041A5 (enExample)
NO20053600L (no) Pyrazolo (3,4-b)pyridinforbindelser og anvendelse derav som fosfodiesterase inhibitorer.
RU99128053A (ru) Новые циклические соединения диамина и содержащие их лекарственные средства
RU2007114293A (ru) Диаминотриазольные соединения, применяемые в качестве ингибиторов протеиновой киназы
JP2022523154A5 (enExample)
JP2021535174A5 (enExample)
RU2015151834A (ru) Ингибиторы киназы
CA2526211C (en) [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof
RU2007118687A (ru) Триазолы, используемые в качестве ингибиторов протеинкиназ
RU2009119181A (ru) Гетероциклические соединения и их применение в качестве ингибиторов гликогенсинтаза-киназы-3
RU2013152961A (ru) Изоксазолины в качестве терапевтических агентов